다우존스 지수

실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.

등록

FEMY

Femasys (FEMY)

Femasys Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:FEMY

1 2 3 4 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/04/18	21:30	GlobeNewswire Inc.	Femasys CEO and Founder Kathy Lee-Sepsick Meets with Members of Congress to Raise Awareness of the Company and Discuss Women’s Healthcare Initiatives	NASDAQ:FEMY	Femasys Inc
2024/03/29	05:05	GlobeNewswire Inc.	Femasys Announces Financial Results for Year Ended December 31, 2023 and Provides Corporate Update	NASDAQ:FEMY	Femasys Inc
2024/03/21	22:00	GlobeNewswire Inc.	Femasys Invites Investors to View Fireside Chat Today, March 21, 2024, to Discuss the Infertility Treatment Landscape	NASDAQ:FEMY	Femasys Inc
2024/03/20	21:15	GlobeNewswire Inc.	Femasys Announces Positive Topline Data from Pivotal Trial for its FDA-Cleared FemaSeed® for the Treatment of Infertility	NASDAQ:FEMY	Femasys Inc
2024/03/13	22:00	GlobeNewswire Inc.	Femasys to Participate in Fireside Chat to Discuss the Infertility Treatment Landscape on March 21, 2024	NASDAQ:FEMY	Femasys Inc
2024/03/06	23:09	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:FEMY	Femasys Inc
2024/03/06	23:00	GlobeNewswire Inc.	Femasys Completes the First In-Office Commercial Procedure with the FDA-Cleared FemaSeed Infertility Solution	NASDAQ:FEMY	Femasys Inc
2024/02/28	23:16	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:FEMY	Femasys Inc
2024/02/14	11:47	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:FEMY	Femasys Inc
2024/02/14	11:44	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:FEMY	Femasys Inc
2024/02/06	22:47	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:FEMY	Femasys Inc
2024/02/03	06:43	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:FEMY	Femasys Inc
2024/02/03	06:42	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:FEMY	Femasys Inc
2024/02/03	06:42	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:FEMY	Femasys Inc
2023/12/11	14:15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:FEMY	Femasys Inc
2023/12/08	23:28	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:FEMY	Femasys Inc
2023/12/01	07:17	Edgar (US Regulatory)	Form S-3 - Registration statement under Securities Act of 1933	NASDAQ:FEMY	Femasys Inc
2023/11/30	06:05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:FEMY	Femasys Inc
2023/11/23	06:39	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:FEMY	Femasys Inc
2023/11/23	06:33	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:FEMY	Femasys Inc
2023/11/23	06:12	Edgar (US Regulatory)	Form D - Notice of Exempt Offering of Securities	NASDAQ:FEMY	Femasys Inc
2023/11/22	07:30	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:FEMY	Femasys Inc
2023/11/16	07:19	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:FEMY	Femasys Inc
2023/11/15	22:30	Business Wire	PharmaCyte Biotech Acquires $5 Million Stake in Emerging Women’s Health Innovator Femasys, Inc.	NASDAQ:FEMY	Femasys Inc
2023/11/02	10:40	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:FEMY	Femasys Inc
2023/10/11	21:01	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:FEMY	Femasys Inc
2023/10/03	22:28	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:FEMY	Femasys Inc
2023/10/03	22:27	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:FEMY	Femasys Inc
2023/09/27	21:19	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:FEMY	Femasys Inc
2023/09/07	06:00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:FEMY	Femasys Inc

검색 관련기사 보기:NASDAQ:FEMY

1 2 3 4 다음 >>

Invesco QQQ Trust Series 1

Financial Select Sector

US Dollar vs Euro

BNP Paribas (QX)

JP Morgan Chase

Health Care Select Sector

Gold vs US Dollar

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관